These entities are characterized by a common pathogenic mechanism involving the formation of antibodies directed against PF4 tetrameric complexes, liable to produce a prothrombotic coagulopathy associated with thrombocytopenia. The gene discussed is PF4; the disease is Thrombocytopenia.